Literature DB >> 22732216

Glycoscience aids in biomarker discovery.

Serenus Hua1, Hyun Joo An.   

Abstract

The glycome consists of all glycans (or carbohydrates) within a biological system, and modulates a wide range of important biological activities, from protein folding to cellular communications. The mining of the glycome for disease markers represents a new paradigm for biomarker discovery; however, this effort is severely complicated by the vast complexity and structural diversity of glycans. This review summarizes recent developments in analytical technology and methodology as applied to the fields of glycomics and glycoproteomics. Mass spectrometric strategies for glycan compositional profiling are described, as are potential refinements which allow structure-specific profiling. Analytical methods that can discern protein glycosylation at a specific site of modification are also discussed in detail. Biomarker discovery applications are shown at each level of analysis, highlighting the key role that glycoscience can play in helping scientists understand disease biology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22732216     DOI: 10.5483/bmbrep.2012.45.6.132

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  16 in total

1.  Validation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer.

Authors:  Yun-Peng Zhao; Ping-Ting Zhou; Wei-Ping Ji; Hao Wang; Meng Fang; Meng-Meng Wang; Yue-Peng Yin; Gang Jin; Chun-Fang Gao
Journal:  Clin Exp Med       Date:  2015-12-29       Impact factor: 3.984

2.  Glycoengineering of Mammalian Expression Systems on a Cellular Level.

Authors:  Kelley M Heffner; Qiong Wang; Deniz Baycin Hizal; Özge Can; Michael J Betenbaugh
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

3.  Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer.

Authors:  Serenus Hua; Cynthia C Williams; Lauren M Dimapasoc; Grace S Ro; Sureyya Ozcan; Suzanne Miyamoto; Carlito B Lebrilla; Hyun Joo An; Gary S Leiserowitz
Journal:  J Chromatogr A       Date:  2013-01-11       Impact factor: 4.759

4.  Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer.

Authors:  Kyoungmi Kim; L Renee Ruhaak; Uyen Thao Nguyen; Sandra L Taylor; Lauren Dimapasoc; Cynthia Williams; Carol Stroble; Sureyya Ozcan; Suzanne Miyamoto; Carlito B Lebrilla; Gary S Leiserowitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-20       Impact factor: 4.254

5.  Isomer-specific LC/MS and LC/MS/MS profiling of the mouse serum N-glycome revealing a number of novel sialylated N-glycans.

Authors:  Serenus Hua; Ha Neul Jeong; Lauren M Dimapasoc; Inae Kang; Chanyoung Han; Jong-Soon Choi; Carlito B Lebrilla; Hyun Joo An
Journal:  Anal Chem       Date:  2013-04-18       Impact factor: 6.986

6.  Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures.

Authors:  John S Strum; Charles C Nwosu; Serenus Hua; Scott R Kronewitter; Richard R Seipert; Robert J Bachelor; Hyun Joo An; Carlito B Lebrilla
Journal:  Anal Chem       Date:  2013-05-24       Impact factor: 6.986

7.  Differentiation of cancer cell origin and molecular subtype by plasma membrane N-glycan profiling.

Authors:  Serenus Hua; Mary Saunders; Lauren M Dimapasoc; Seung Hyup Jeong; Bum Jin Kim; Suhee Kim; Minkyung So; Kwang-Sik Lee; Jae Han Kim; Kit S Lam; Carlito B Lebrilla; Hyun Joo An
Journal:  J Proteome Res       Date:  2014-01-08       Impact factor: 4.466

Review 8.  Disrupted Glycocalyx as a Source of Ocular Surface Biomarkers.

Authors:  Pablo Argüeso
Journal:  Eye Contact Lens       Date:  2020-03       Impact factor: 3.152

9.  Multivariate proteomic analysis of the cerebrospinal fluid of patients with peripheral neuropathic pain and healthy controls - a hypothesis-generating pilot study.

Authors:  Emmanuel Bäckryd; Bijar Ghafouri; Anders K Carlsson; Patrik Olausson; Björn Gerdle
Journal:  J Pain Res       Date:  2015-07-01       Impact factor: 3.133

Review 10.  The sweet and sour of serological glycoprotein tumor biomarker quantification.

Authors:  Uros Kuzmanov; Hari Kosanam; Eleftherios P Diamandis
Journal:  BMC Med       Date:  2013-02-07       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.